Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4183217 | L'Encéphale | 2006 | 9 Pages |
Abstract
As expected, the main indication for prescribing clozapine was resistant schizophrenia, but contrary to data from the international literature, the efficacy profile was the same whatever the clinical subtype of schizophrenia. The tolerance to clozapine was considered on the whole as satisfactory, but the high proportion of granulopenias leading to treatment withdrawal (5.2 % of patients) confirms the need to remain cautious and stresses the importance of regular haematological monitoring. Furthermore, the study of the prescription modalities of clozapine shows that contrary to the guidelines, clozapine is often associated with other psychotropic drugs. In this study, it is striking to note that 75 % of granulopenias occured in a coprescription situation.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
S. Hiltgen, S. Mantelet, F. Pinabel, F. Enjaume,